Russian company developed portable devices for electrocardiography and electrostimulation, including an evaluation method of cardiovascular system and electrostimulation with control of the process in real time. The company looks for partners in foreign countries to conclude manufacturing agreement and joint venture agreement.
The Russian company from Sverdlovsk region specialises in developing cardiocontrollers, the portable devices for electrocardiography and electrostimulation. The cardiocontroller is designed for the early diagnosis and prevention of possible progression of pathological and critical conditions in order to take timely measures for preservation of personal safety; authorized persons or organizations are notified about the results of the examination by means of the GSM module. The assessment of heart rate variability offers the possibility of evaluating the activity index of the regulatory systems. The regulatory systems are multilevel systems of internal management, consisting of blood circulatory system, cerebral cortex, hypothalamus, spinal cord, adrenal glands, etc. which, directly or indirectly, define the quality of intercourse of an organism with the environment. The cardiocontroller provides: 1. Improvement of life safety and increase of lifetime due to quick assessment of current state of the cardiovascular system (CVS) and detection of pathologies at early stages of their development with automatic issue of the conclusion and practical recommendations. 2. Control of therapeutic approaches and physical activities productivity. 3. Monitoring of CVS parameters dynamics for the periods of time 4. Visual monitoring of the cardiogram, cardiogram intervals in real time and calculation of indicators of CVS regulation. Nowadays the project exists at the stage of an industrial prototype. For organizing the manufacturing of its products the company is looking for partners from different spheres to collaborate under joint venture agreement and manufacturing agreement. Detailed terms of the agreements will be discussed with each potential partner individually.
Innovations and advantages
The method of heart rate variability has received the world recognition. The main difference of the cardiocontroller from the existing analogs is its portability, usability for telemedicine, capability of its usage in the form of an application for Android and iOS smartphones with data transmission to processing centers and "organization of the alarm button" of the software. The difference of the “Cardiocontroller” from the existing analogs is that the proposed device is verified in Bayevsky’s laboratory, it is authentic to the author's methodology. Moreover, another difference is related to its portability, usability for telemedicine, capability of its usage in the form of an application Android and iOS smartphones with data transmission to processing centers and "organization of the alarm button" of the software. The device has two software versions. The first one is designed for experts, and the other one – for common users without special knowledge. For experts the information about the results of assessment is provided in strictly scientific terminology, and for common users – there is an adapted version with "easy" formulations and convincing recommendations for further necessary actions.
06001005 Diagnostics, Diagnosis
06001007 Emergency medicine
06001011 Heart and blood circulation illnesses
06001012 Medical Research
Market application codes
05001001 Diagnostic services
Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Latvia, Lithuania, Luxembourg
Type of partner sought
Type of partner: SMEs. Field of activity: medicine, practice of the diagnosis, treatment, and prevention of disease. Partner's role: in the framework of manufacturing agreement to produce cardiocontrollers for clients by orders. In the framework of joint venture agreement to organize production chain of items for public usage.